Manipal Hospital:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Manipal Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9298
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Manipal Hospital, formerly Manipal Health Systems is a healthcare service provider that offers primary, secondary and tertiary healthcare services. The hospital offers services such as robotic assisted surgery, eye care, rehabilitation, skin care, accident and emergency care, child care, dental care, home healthcare, and others. It provides services in the areas of cardiovascular, neurology, nephrology, oncology, urology, dental science and metabolic disorders, among others. Manipal Hospital also provides services in therapeutic areas such as andrology, lab diagnostics, sports medicine, psychology, general medicine, and others. The hospital operates through its healthcare centers in Tumkur, Salem, Mangalore, Goa, Vijayawada, Vishakhapatnam, and others. Manipal Hospital is headquartered in Bangalore, Karnataka, India.

Manipal Hospital – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Manipal Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Manipal Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Manipal Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Manipal Hospital, Medical Devices Deals, 2012 to YTD 2018 8
Manipal Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Manipal Hospital, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Manipal Health Plans to Acquire Balabhai Nanavati Hospital in India 10
Manipal Health Enterprises Acquires Malaysia-Based Hospital 11
Private Equity 12
Manipal Health Systems Raises US$100 Million In Private Equity Financing From India Value Fund Advisors 12
Manipal Health Systems Plans To Raise Additional US$100 Million In Private Equity Financing From India Value Fund Advisors 13
Acquisition 14
Manipal Health Systems Acquires 51% Stake In Ankur Healthcare For US$7.3 Million 14
Manipal Hospital – Key Competitors 15
Manipal Hospital – Key Employees 16
Manipal Hospital – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Manipal Hospital, Pharmaceuticals & Healthcare, Key Facts 2
Manipal Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Manipal Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Manipal Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Manipal Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Manipal Hospital, Medical Devices Deals, 2012 to YTD 2018 8
Manipal Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Manipal Health Plans to Acquire Balabhai Nanavati Hospital in India 10
Manipal Health Enterprises Acquires Malaysia-Based Hospital 11
Manipal Health Systems Raises US$100 Million In Private Equity Financing From India Value Fund Advisors 12
Manipal Health Systems Plans To Raise Additional US$100 Million In Private Equity Financing From India Value Fund Advisors 13
Manipal Health Systems Acquires 51% Stake In Ankur Healthcare For US$7.3 Million 14
Manipal Hospital, Key Competitors 15
Manipal Hospital, Key Employees 16
Manipal Hospital, Other Locations 17
Manipal Hospital, Subsidiaries 17

List of Figures
Manipal Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Manipal Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Manipal Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Manipal Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Manipal Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Manipal Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Manipal Hospital, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Manipal Hospital:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • San Miguel Brewery Inc:企業の戦略・SWOT・財務情報
    San Miguel Brewery Inc - Strategy, SWOT and Corporate Finance Report Summary San Miguel Brewery Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Feintool International Holding AG (FTON):企業の財務・戦略的SWOT分析
    Feintool International Holding AG (FTON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Petrosibir AB (PSIB B):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrosibir AB (Petrosibir), formerly Shelton Petroleum AB is an oil and gas company. The company offers exploration and development of oil and gas assets and the resource-rich basins in Russia and Ukraine. It holds Ayazovskoye production license and Rustamovskoye exploration license that cov …
  • UAC of Nigeria PLC:企業の戦略・SWOT・財務情報
    UAC of Nigeria PLC - Strategy, SWOT and Corporate Finance Report Summary UAC of Nigeria PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pakistan Oxygen Limited (LINDE):企業の財務・戦略的SWOT分析
    Pakistan Oxygen Limited (LINDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Charoen Pokphand Foods Public Co Ltd (CPF):企業の財務・戦略的SWOT分析
    Charoen Pokphand Foods Public Co Ltd (CPF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Mistras Group Inc (MG):企業の財務・戦略的SWOT分析
    Summary Mistras Group Inc (Mistras) is a provider of technology-enabled asset protection solutions that offers used to evaluate the structural integrity of critical energy, industrial and public infrastructure. The company provides products such as acoustic emission, ultrasonic, and vibration and Pd …
  • Suzlon Energy Ltd (SUZLON):企業の財務・戦略的SWOT分析
    Suzlon Energy Ltd (SUZLON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Exeltis Pharmaceuticals Holding SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Exeltis Pharmaceuticals Holding SL (Exeltis), a subsidiary of Insud Pharma, is a developer, producer, and marketer of medicinal products and medical devices. The company provides products in the therapeutic areas including women’s health, dermatology, respiratory, central nervous system, inf …
  • DCS Corporation:企業の戦略・SWOT・財務情報
    DCS Corporation - Strategy, SWOT and Corporate Finance Report Summary DCS Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Securitas AB (SECU B):企業の財務・戦略的SWOT分析
    Securitas AB (SECU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Navios Maritime Partners L.P.:企業のM&A・事業提携・投資動向
    Navios Maritime Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Navios Maritime Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Limacorporate SpA:医療機器:M&Aディール及び事業提携情報
    Summary Limacorporate SpA (Lima) is a medical device company that develops, manufactures and commercializes reconstructive and fixation orthopaedic solutions. The company offers large joint primary and revision implants, extremities and fixation and promade products. It provides medical devices for …
  • IBC Solar AG:企業の戦略的SWOT分析
    IBC Solar AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Companhia Energetica de Sao Paulo (CESP6)-エネルギー分野:企業M&A・提携分析
    Summary Companhia Energetica de Sao Paulo (CESP) is a state-owned integrated electric utility. It plans, constructs, and operates electric energy generation and commercialization systems. The company generates energy from hydro source. CESP owns power plants at at Rio Paran, Rio Paraibuna, and Rio J …
  • Innovent Biologics Inc (1801):製薬・医療:M&Aディール及び事業提携情報
    Summary Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that discovers, develops and manufactures monoclonal antibodies. The company offers monoclonal antibodies such as IBI301, IBI302 and IBI303, among others. Its products are used for the treatment of non-Hodgkin’s lymph …
  • ValiRx Plc (VAL):企業の財務・戦略的SWOT分析
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing …
  • Lloyd’s of London:企業の戦略・SWOT・財務情報
    Lloyd's of London - Strategy, SWOT and Corporate Finance Report Summary Lloyd's of London - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Forty Seven Inc (FTSV):製薬・医療:M&Aディール及び事業提携情報
    Summary Forty Seven Inc (Forty Seven), formerly CD47 Sciences Inc is a clinical-stage immuno-oncology company that focuses on the development of therapies to treat cancer. The company’s lead molecule Hu5F9-G4 is a monoclonal antibody that is used against the CD47 receptor. Its monoclonal antibody is …
  • CITIC Telecom International Holdings Ltd (1883):企業の財務・戦略的SWOT分析
    CITIC Telecom International Holdings Ltd (1883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆